Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the human chorionic gonadotropin market right now?

Recent years have seen a robust growth in the size of the human chorionic gonadotropin market. An expansion from $0.95 billion in 2024 to $1.03 billion in 2025, reflecting an annual growth rate (CAGR) of 8.7%, is anticipated. The growth during the historical period is attributable to factors such as an increasing incidence of hypogonadism in elderly individuals, heightened awareness of HCG among healthcare practitioners and patients, rising popularity of fertility tourism, expanding geriatric population, and improvements in affordability and healthcare facilities.

How fast Is the human chorionic gonadotropin market expected to grow, and what’s its future value?

The market for human chorionic gonadotropin is anticipated to witness significant expansion in the upcoming years, reaching a valuation of $1.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.4%. This expected growth during the forecasted timeline can be ascribed to the escalating cases of infertility, a growing number of women suffering from polycystic ovary syndrome, increasing incidences of female infertility, and an elevated utilization of HCG in veterinary medicine. The forecast period is also expected to see prime trends such as advancements in detecting pregnancy, novel drug compositions, technology infusion in this sector, emphasis on research and innovation, and introduction of new products.

Get your human chorionic gonadotropin market report here!

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

What are the leading drivers of growth in the human chorionic gonadotropin market?

The surge in infertility rates is predicted to propel the advancement of the human chorionic gonadotropin market in the future. Infertility is understood as the incapability to conceive after a minimum of one year of regular, unprotected sexual intercourse. More individuals and couples are having trouble conceiving because of factors such as delayed childbearing, shifts in lifestyle habits, exposure to environmental contaminants, and health conditions, which has resulted in the rise of infertility rates. Human chorionic gonadotropin (hCG) is utilized in infertility therapies to initiate ovulation in women and boost testosterone production in men, thus ensuring the discharge of eggs and enhancing fertility results. For example, in April 2023, the World Health Organization, a Switzerland-based international organization, reported that about 17.5% of the worldwide adult population, or approximately one-sixth of the entire human population, suffered from infertility, underscoring the urgent requirement for affordable, superior quality fertility healthcare for those who require it. Consequently, the rising rate of infertility is stimulating the expansion of the human chorionic gonadotropin market.

What are the key segments defining the human chorionic gonadotropin market?

The human chorionic gonadotropin market covered in this report is segmented –

1) By Technology: Natural Source Extraction, Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine, Extraction From Animal Sources

2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp

Who are the key players steering the development of the human chorionic gonadotropin market?

Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.

What are the key trends shaping the future of the human chorionic gonadotropin market?

Leading firms in the human chorionic gonadotropin market are concentrating on the creation of ground-breaking products such as pregnancy detection kits to enhance diagnostic accuracy, better patient outcomes, and broaden their market presence. Pregnancy detection kits are instruments used to confirm a person’s pregnancy by detecting human chorionic gonadotropin (hCG) in the body. For example, in June 2022, Proov, a medical equipment manufacturing firm based in the US, introduced newly designed hCG tests specifically for early pregnancy detection. This allows women to confirm their pregnancy up to six days before their anticipated period. These tests work by detecting human chorionic gonadotropin (hCG) in urine. They offer a high level of accuracy with a reliability rate of over 99. With this innovation, women are given a trustworthy and easy-to-access way to check their pregnancy status earlier than conventional tests, enabling them to make well-informed decisions about their reproductive health.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18638

Which regions are most influential in expanding the human chorionic gonadotropin market?

North America was the largest region in the human chorionic gonadotropin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Mineral And Bone Disorder Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

Anorectal Disorders Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Cleanroom Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cleanroom-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: